How a Foreign Corrupt Practices Act investigation turned the chief legal officer of Bio-Rad Laboratories into the company's chief legal adversary.
April 28, 2017 at 02:08 PM
1 minute read
The Friday afternoon meeting on June 7, 2013, between Sanford “Sandy” Wadler and Norman Schwartz started out like most weekly check-ins between the two Bio-Rad Laboratories Inc. senior executives.
Wadler, the company’s longtime general counsel, walked four doors down the hall in the company’s Northern California headquarters to the office of Schwartz, Bio-Rad’s CEO. Wadler had a seat and began talking about the latest pressing legal issues at the Fortune 1000 life sciences company.
Presented by BigVoodoo
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
Honoring outstanding legal achievements focused at the national level, largely around Big Law and in-house departments.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Lower Manhattan firm seeks a premises liability litigator (i.e., depositions, SJ motions, and/or trials) with at least 3-6 years of experien...
At NJM, a top-rated insurance company, we are seeking an Attorney on our Workers Compensation legal team with between 3 and 5 years of expe...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
The American Lawyer provides the most informed and trusted source of news, data, analysis and forecasting on the global business of law.
